Financial Technology

Financial Technology - INDUSTRY NEWS

Share

TMCNet:  Stock to Watch: RTI Biologics Down 11.7% (RTIX)

[February 07, 2013]

Stock to Watch: RTI Biologics Down 11.7% (RTIX)

Feb 07, 2013 (SmarTrend(R) Spotlight via COMTEX) -- RTI Biologics (NASDAQ:RTIX) is one of today's worst performing low-priced stocks, down 11.7% to $4.19 on 1.3x average daily volume. RTI Biologics has traded 283,000 shares thus far today, vs. average volume of 223,000 shares per day. The stock has underperformed the Dow (-11.7% to the Dow's -0.7%) and underperformed the S&P 500 (-11.7% to the S&P's -0.7%) during today's trading.
Story continues below ↓

Potential upside of 15.5% exists for RTI Biologics, based on a current level of $4.18 and analysts' average consensus price target of $4.83. The stock should find resistance at its 50-day moving average (MA) of $4.31, as well as support at its 200-day MA of $3.97.

RTI Biologics, Inc. processes human and animal musculoskeletal tissues in producing allograft and xenograft implants. The Company's products are used by surgeons to repair bone and other tissue defects, such as vertebrae repair, musculoskeletal reconstruction, fracture repair, joint repair and reconstruction for sports medicine injuries.

RTI Biologics share prices have moved between a 52-week high of $5.11 and a 52-week low of $2.54 and are now trading 65% above that low price at $4.18 per share. The 200-day and 50-day moving averages have moved 0.47% higher and 0.56% higher over the past week, respectively.

SmarTrend recommended that subscribers consider buying shares of RTI Biologics on August 7th, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $3.82. Since that recommendation, shares of RTI Biologics have risen 24.1%. We continue to monitor RTIX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Write to Chip Brian at cbrian@mysmartrend.com --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To Financial Technology's Homepage ]